Contents

Symposium on Stem cells: nuclear reprogramming and therapeutic applications, held at the Novartis Foundation, London, 2–4 March 2004.

Editors: Gregory Bock (Organizer) and Jamie Goode

This symposium is based on proposals made by Karin Blumer and Uwe Junker, and Adam Wilkins

John Gearhart 
Chair’s introduction

Davor Solter 
What is a stem cell?
Abstract
Discussion

Markus Grompe 
Bone marrow-derived hepatocytes
Abstract
Discussion

Irving L. Weissman 
Normal and neoplastic stem cells
Abstract
Discussion

Catherine M. Verfaillie 
Multipotent adult progenitor cells: an update
Abstract
Discussion

Steven A. Goldman and Fraser Sim 
Neural progenitor cells of the adult brain
Abstract
Discussion

General discussion I 
Stem cells in the brain

Martin Evans 
Embryonic stem cells: a perspective
Abstract
Discussion

Rudolf Jaenisch, Konrad Hochedlinger and Kevin Eggan 
Nuclear cloning, epigenetic reprogramming and cellular differentiation
Abstract
Discussion

General discussion II

J. B. Gurdon, J. A. Byrne and S. Simonsson 
Nuclear reprogramming by Xenopus oocytes
Abstract
Discussion

Bernardo Nadal-Ginard, Piero Anversa, Jan Kajstura and Annarosa Leri 
Cardiac stem cells and myocardial regeneration
Abstract
Discussion

Bernat Soria, Enrique Roche, Juan A. Reig and Franz Martin 
Generation of insulin-producing cells from stem cells
Abstract
Discussion

Anders Björklund 
Cell therapy for Parkinson’s disease: problems and prospects
Abstract
Discussion

Thomas H. Murray 
Ethical (and political) issues in research with human stem cells
Abstract
Discussion

Final discussion 
The regulatory environment

Return to the catalogue

This page was last updated on 23 March 2005